CNXU — Conexeu Sciences Balance Sheet
0.000.00%
Annual balance sheet for Conexeu Sciences, fiscal year end - October 31st, USD millions except per share, conversion factor applied.
2023 October 31st | 2024 October 31st | 2025 October 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Cash and Equivalents | |||
| Cash and Short Term Investments | 0 | 0.315 | 4.81 |
| Net Total Receivables | — | — | 2.07 |
| Prepaid Expenses | |||
| Total Other Current Assets | |||
| Total Current Assets | 0 | 0.347 | 7.46 |
| Gross Property, Plant And Equipment | |||
| Accumulated Depreciation | |||
| Net Property, Plant And Equipment | — | — | 0.011 |
| Net Intangible Assets | |||
| Other Long Term Assets | |||
| Total Assets | 0 | 0.534 | 7.69 |
| Payable / Accrued | |||
| Notes Payable / Short Term Debt | |||
| Total Other Current Liabilities | |||
| Total Current Liabilities | 0.035 | 0.341 | 0.336 |
| Long Term Debt | |||
| Total Long Term Debt | |||
| Total Debt | |||
| Total Liabilities | 0.035 | 0.439 | 0.336 |
| Common Stock | |||
| Additional Paid In Capital | |||
| Retained Earnings (Accumulated Deficit) | |||
| Total Equity | -0.035 | 0.095 | 7.35 |
| Total Liabilities & Shareholders' Equity | 0 | 0.534 | 7.69 |
| Total Common Shares Outstanding |